US Food and Drug Administration (FDA)

FDA to take new approach on homeopathic products

The US Food and Drug Administration is to introduce a new ‘risk-based enforcement approach’ to drug products that are labeled ‘homeopathic’ and available on the American market.…

FDA approves first biosimilar for breast and stomach cancers

The first biosimilar for the treatment of breast and stomach cancers has been approved by the US Food and Drug Administration…

Digital ingestion tracking system in pills and medication adherence: future advantages and current limitations

The US Food and Drug Administration (FDA)’s approval of the first-ever digital pill, Abilify MyCite, an aripiprazole tablet for the treatment of schizophrenia, marks the closest we have come to revolutionising the way the uptake of pills is monitored[1] . On a global scale, the …

FDA approves cancer genetic test

The US Food and Drug Administration has approved a genetic test that can detect mutations in solid tumours in 324 genes…

Competing drugs to treat opioid addiction equally safe, according to study

Two of the main medicines used for treating opioid addiction are equally safe and effective, according to a new study in The Lancet.…

First two-drug HIV treatment approved by FDA

The US Food and Drug Administration has approved the first two-drug treatment regimen for the treatment of human immunodeficiency virus type 1 (HIV-1)…

FDA approves first digital pill

The first pill which can be digitally tracked as it makes its way through the body has been approved for use by the US safety drugs watchdog, the Food and Drug Administration.…

Too many cancer drugs, too few survival benefits

balke…

Methadone and buprenorphine to be used to tackle US opioid crisis

The US Food and Drug Administration plans to encourage greater use of what it regards as less harmful opioid drugs, such as methadone and buprenorphine, to manage addiction to prescription opioids in a radical shift in policy.…

FDA announces $22m for research into products for patients with rare diseases

The US Food and Drug Administration (FDA) has announced research grants of more than $22m to develop products for patients with rare diseases over the next four years.…